LACHEN, Switzerland-Wednesday, July 12th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- Octapharma is pleased to announce the success of yesterday’s symposium at the International Society on Thrombosis and Haemostasis (ISTH) congress held in Berlin, Germany. As platinum sponsors of the congress, Octapharma is reflecting its dedication to bleeding disorder research with two diverse scientific symposia in von Willebrand disease (VWD) and haemophilia A (HA). Following on from a successful symposium on Nuwiq® (the company’s most recent addition to their expanding haematology portfolio), the latest developments with wilate®, a high purity, double virus-inactivated VWF/FVIII concentrate containing both factors in a physiological 1:1 ratio, were discussed on Monday 10th July in a symposium entitled, “wilate® for a Lifetime of Care, Bleeding Management across High-Risk Patient Populations”. The symposium, chaired by Professor Ute Scholz (Centre of Coagula ... Read more »

 Patent submissions continue to be accepted 

DENVER-Tuesday, July 11th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- World licensing leader MPEG LA, LLC is pleased to announce that key CRISPR patent holders have submitted patents in response to MPEG LA’s call to participate in the creation of a global CRISPR-Cas9 Joint Licensing Platform and that patent submissions continue to be accepted.

“The enthusiastic response to MPEG LA’s patent pool initiative is further evidence of the widely held view that CRISPR is too important to be left at risk of endless patent battles and splintered licensing regimes and that a pool providing one-stop licensing efficiency and predictability to scientists and businesses worldwide represents the best hope to unleash its life-enhancing potential,” said Larry Horn, President and CEO of MPEG LA. “As MPEG LA’s objective is to provide worldwide access to as much CRISPR intellectual property as p ... Read more »

NEW YORK-Tuesday, July 11th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- GC Securities, a division of MMC Securities LLC, a U.S. registered broker-dealer and member FINRA/NFA/SIPC, today announced the placement of Principal At-Risk Variable Rate Notes, with notional principal at €200,000,000, through a newly formed special purpose vehicle domiciled in Ireland, Lion II Re DAC, to benefit Assicurazioni Generali S.p.A., an Italian insurance company and the parent company of the Generali Group. This is the third time that Assicurazioni Generali S.p.A. has utilized the insurance-linked securities market and is the first ever 144A cat bond to provide indemnity protection against multiple Europe perils.

The bond provides four years of per occurrence indemnity protection for Europe windstorms and Europe flood affecting selected European countries and earthquakes affecting Italy. It is also the first time that Europe flood has been covered in a 144A cat bond.

GC Securi ... Read more »